PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 1, 2024Clinical Transplantation10 citations

Impact of OPTN policy 3.7D providing waiting time modification for candidates affected by race‐inclusive eGFR calculations: Early results from a single center

View Full Paper
AHArika HoffmanSWScott G. WestphalDWDebra Wekesa

Key Points

Key points are not available for this paper at this time.

Abstract

Abstract Introduction OPTN Policy 3.7D, implemented January 5, 2023, mandates that all kidney transplant programs modify waiting time for candidates affected by race‐inclusive eGFR calculations. We report the early impact of this policy change. Methods Our transplant program reviewed all listed transplant candidates and identified patients potentially eligible for waiting time modification. Eligible candidates received waiting time modification after submission of supporting evidence to the OPTN. We reviewed the impact on waiting time and transplant activity through October 1, 2023. Results Forty‐six adult patients on our center's active waiting list self‐identified as Black/African American. 25 (54.3%) candidates qualified for waiting time modification. A median 451 (321, 1543.5) additional days of waiting time was added for qualifying patients. Of the 25 patients who qualified for waiting time modification, 11 patients received a deceased donor kidney in the early period following waiting time modification, including 5 patients transplanted within 1 month after modification. Conclusions Policy 3.7D is one of few national mandates to address specifically structural racism within transplantation. Implementation has yielded near immediate effects with greater than 40% of time‐adjusted patients at our center receiving a deceased donor kidney transplant in the initial months after policy enactment. Early assessment demonstrates great potential impact for this policy.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Hoffman et al. (2024) studied this question.

synapsesocial.com/papers/68e764abb6db6435876da712https://doi.org/10.1111/ctr.15273
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Reviewing Racial Disparities in Living Donor Kidney Transplantation: a Socioecological Approach2023 · 28 citations
  2. 2Racial/ethnic disparities in waitlisting for deceased donor kidney transplantation 1 year after implementation of the new national kidney allocation system2018 · 116 citations
  3. 3Trends in Disparities in Preemptive Kidney Transplantation in the United States2019 · 103 citations
  4. 4A Cascade of Structural Barriers Contributing to Racial Kidney Transplant Inequities2021 · 34 citations
  5. 5A Unifying Approach for GFR Estimation: Recommendations of the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Disease2021 · 424 citations